Nicole Williams
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
132
Citations
1,706
Est. group size
~35
Recurring co-author estimate
Active years
30
Publishing since 1996
This publication record is associated with the name Nicole Williams and centers on breast cancer research, including clinical trials of new drug combinations (such as antibody-drug conjugates, immunotherapies, and targeted therapies), biomarkers for cancer subtypes, and care-related topics like geriatric oncology and cancer pain management in older adults. The work spans early-phase and multi-site clinical trials as well as reviews on treatment strategies and patient quality of life. Because bibliographic name-matching can combine records from multiple individuals, this profile may reflect contributions from more than one researcher sharing this name.
Publication output rose sharply from 2017-2019, peaked around 2020-2021, and has gradually declined through 2022-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Shock: what is it and how is it managed?
The Veterinary Nurse · 2025
- Abstract P1-09-19: IRENE study: Phase 2 study of oncolytic virus pelareorep and PD-1 inhibitor retifanlimab in metastatic triple negative breast cancer
Clinical Cancer Research · 2025
- Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
Nature Medicine · 2024
- Rates of pathologic complete response (pCR)after neoadjuvant datopotamab deruxtecan (Dato): Results from the I-SPY2.2 trial.
Journal of Clinical Oncology · 2024
- IDF23-0250 The accuracy of non-invasive markers for advanced non-alcoholic fatty liver disease fibrosis in people with T2D
Diabetes Research and Clinical Practice · 2024
- Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity
Antibodies · 2023
- Abstract GS5-03: Evaluation of anti-PD-1 Cemiplimab plus anti-LAG-3 REGN3767 in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL
Cancer Research · 2023
- Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Current Treatment Options in Oncology · 2022
- Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium
The Lancet Healthy Longevity · 2022
- Impact of Dose Intensity on Pathologic Complete Response Rate in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab and Pertuzumab (TCHP)
Targeted Oncology · 2022
- Right Sizing Systemic Therapy for Patients with Breast Cancer. Where are we Today?
Current Breast Cancer Reports · 2022
- Abstract OT2-25-01: Irene study: Phase 2 study of Incmga00012 and the oncolytic virus pelareorep in metastatic triple negative breast cancer
Cancer Research · 2022
- Hospital Admissions Associated With Cancer Pain in Older Adults With and Without Dementia
Pain Management Nursing · 2021
- Abstract PS11-02: Comprehensive comparative analysis of invasive ductal and lobular breast cancer cases in great lakes breast cancer consortium
Cancer Research · 2021
- PCN123 Hospital Admissions Associated with Cancer Pain and Dementia in Older Adults
Value in Health · 2021
- Cancer Research×19
- Journal of Clinical Oncology×17
- Research Square×6
- JAMA Network Open×3
- Brain Behavior and Immunity×3
- Julie Stephens
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Mathew Cherian
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Bhuvaneswari Ramaswamy
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kai Johnson
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- JY Kim
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile